OMAR Opioid Use Disorder
Yale University · with National Institute on Drug Abuse (NIDA) · NCT05683184
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 1
- Target enrollment
- 30
- US sites recruiting
- 1
- Study start
- March 10, 2023
- Record last updated
- September 10, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this research study is to examine the endocannabinoid (eCB) function in vivo in individuals with opioid use disorder (OUD) by measuring cannabinoid receptor 1 (CB1R) availability.
Being studied: [11C]OMAR
Conditions: Healthy Control; Opioid Use Disorder
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Able to provide informed consent
- Male and female 18 years and older
- DSM-5 diagnosis of opioid use disorder (for OUD group)
- Physically healthy i.e., no clinically unstable medical conditions
- Written informed consent and have capacity to consent and comply with study procedures
Exclusion Criteria
- Current neuro-psychiatric illness or severe systemic disease (opioid use disorder is permitted in the OUD group).
- Presence of ferromagnetic metal in the body or heart pacemaker
- Have had exposure to ionizing radiation that in combination with the study tracer would result in a cumulative exposure that exceeds recommended exposure limits
- Are claustrophobic
- Hematocrit values lower than 30
Recruiting US locations
Connecticut Mental Health Center, Clinical Neuroscience Research Unit
New Haven, CT 06519
Site contact: Abby Dewey · 475-441-4190 · abigail.dewey@yale.edu
Study contacts (from the official record)
- Anahita Bassir Nia, MD · 203-974-7540 · anahita.bassirnia@yale.edu
- Abby Dewey · 475-441-4190 · abigail.dewey@yale.edu
Similar studies in Connecticut
All healthy volunteers studies in Connecticut →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma
Pfizer
- Location
- New Haven, CT
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersEarly Phase 1Overnight stay mentioned
Investigating the Mu:Kappa Opioid Receptor Imbalance in Alcohol Use Disorder
Yale University
- Location
- New Haven, CT
- Eligibility basics
- Ages 21–70
- RecruitingHealthy volunteersPhase 1
MK-0947 PN-002: An Open-label Study to Evaluate Brain α-synuclein Deposition Using Positron Emission Tomography (PET) and [¹⁸F]MK-0947 in Participants With Parkinson's Disease (PD)
XingImaging, LLC
- Location
- New Haven, CT
- Eligibility basics
- Ages 40–80
- RecruitingHealthy volunteersEarly Phase 1
A Study of the Pharmacokinetics, Biodistribution and Dosimetry of Granzyme-B Targeted [Cu-64]-Labeled PET Radiotracers in Adult Healthy Volunteers
Ratio Therapeutics, Inc.
- Location
- New Haven, CT
- Eligibility basics
- Ages 18–60